Report of rpoB mutation in clinically suspected cases of drug resistant leprosy: a study from Eastern India.

Abstract

BACKGROUND The current strategy for leprosy control depends mainly on early case detection and providing the recommended multidrug therapy (MDT) dosage. Understanding the molecular mechanisms of drug resistance to each of these drugs is essential in providing effective treatment and preventing the spread of resistant strains in the community. The progress… (More)
DOI: 10.4103/0378-6323.152185

Topics

Cite this paper

@article{Reja2015ReportOR, title={Report of rpoB mutation in clinically suspected cases of drug resistant leprosy: a study from Eastern India.}, author={Abu Hena Hasanoor Reja and Nibir Kumar Biswas and Supratik Biswas and Mallika Lavania and Vedithi Sundeep Chaitanya and Surajita Banerjee and Prasanta Sinha Maha Patra and Umesh Gupta and Pradip Kumar Patra and Uttpal Sengupta and Basudev Bhattacharya}, journal={Indian journal of dermatology, venereology and leprology}, year={2015}, volume={81 2}, pages={155-61} }